Showing results (21-30 of 119) with videos related to
Sort By:
Pageof 12
Nutrition and Cancer|April 1, 2020
The Effect of Omega-3 Polyunsaturated Fatty Acid Supplementations on anti-Tumor Drugs in Triple Negative Breast CancerYingjie Ma, Jing Wang, Qin Li, et al.Scientific Reports|October 28, 2015
Efficacy and Safety of Bevacizumab Combined with Chemotherapy for Managing Metastatic Breast Cancer: A Meta-Analysis of Randomized Controlled TrialsQin Li, Han Yan, Pengfei Zhao, et al.Bioscience, Biotechnology, and Biochemistry|January 1, 2020
Addition of docosahexaenoic acid synergistically enhances the efficacy of apatinib for triple-negative breast cancer therapyYingjie Ma, Junxian Yu, Qin Li, et al.Toxicology Letters|February 14, 2013
Paeoniflorin protects human EA.hy926 endothelial cells against gamma-radiation induced oxidative injury by activating the NF-E2-related factor 2/heme oxygenase-1 pathwayJing Yu, Xiaoyun Zhu, Xin Qi, et al.International Immunopharmacology|April 30, 2024
Association of pathological response with long-term survival outcomes after neoadjuvant immunotherapy: A meta-analysisChenyu Wei, Haolin Sun, Jiexuan Hu, et al.Oncology Letters|June 22, 2018
The coordinated effects of Apatinib and Tripterine on the proliferation, invasiveness and apoptosis of human hepatoma Hep3B cellsHuihui Li, Yichang Fan, Fan Yang, et al.Cancer Biotherapy & Radiopharmaceuticals|October 26, 2021
Tumor-Associated Macrophage-Derived Exosomes Promote the Progression of Gastric Cancer by Regulating the P38MAPK Signaling Pathway and the Immune Checkpoint PD-L1Yusheng Wang, Kun Shang, Ninggang Zhang, et al.Journal of Cancer Research and Clinical Oncology|September 7, 2023
Encephalitis in a patient with hypopharynx cancer treated with immune checkpoint inhibitors and radiotherapy: a case report and review of the literatureYan Kang, Hongchao Zhen, Nina Ma, et al.Nutrition and Cancer|February 1, 2022
The Prognostic Value of Albumin-Globulin Ratio and Eosinophil-Neutrophil Ratio in Patients with Advanced Tumors Undergoing Treatment with PD-1/PD-L1 InhibitorsYan Ma, Kun Shang, Shanshan Wu, et al.International Immunopharmacology|September 22, 2024
A nomogram for predicting survival based on hemoglobin A1c and circulating tumor cells in advanced gastric cancer patients receiving immunotherapyChenyu Wei, Haolin Sun, Shujing Liu, et al.Pageof 12